• From Nanoparticle Killing to Viability Evidence

  2026-09-07

  A translational framework for using Calcein AM/PI fluorescence to connect nanoparticle disinfection efficacy with mammalian cell compatibility in root canal research.

• FUS–SMN Phase Separation in Neuronal Granules

  2026-09-05

  Wang and Li show that asymmetric dimethylation of FUS creates binding sites for the oligomeric Tudor-domain protein SMN, enabling multivalent interactions that promote liquid–liquid phase separation and neuronal granule assembly. The study links impaired methylation or reduced SMN valency to defective axonal mRNA distribution and neuronal phenotypes, providing a mechanistic framework for understanding granule dysfunction in spinal muscular atrophy.

• Itraconazole for Candida Biofilm Assays

  2026-09-04

  Itraconazole combines triazole antifungal activity with practical value in Candida biofilm, resistance, CYP3A4, hedgehog, and angiogenesis studies. This workflow shows how to control solubility, separate planktonic from biofilm effects, and test PP2A–autophagy-dependent drug resistance without overinterpreting cross-species potency.

• Live-Dead Cell Staining Kit in 3D Culture

  2026-09-04

  Explore how the Live-Dead Cell Staining Kit can turn viability imaging into a matrix-aware decision tool for 3D culture. This guide connects Calcein-AM Propidium Iodide staining with hydrogel formulation, flow cytometry, microscopy, and more defensible interpretation of cell injury.

• JAK Inhibitors Block RA Synovial Fluid Pain Signaling

  2026-09-03

  This preprint identifies a direct effect of JAK inhibition on human sensory neurons exposed to rheumatoid arthritis synovial fluid. By combining cytokine profiling, transcriptomics, phospho-STAT3 analysis, and neuronal electrophysiology, it links synovial JAK/STAT signaling to pain-relevant neuronal responses and provides a mechanistic rationale for further study of JAK inhibitor analgesia.

• Hybridization Rewired Pluripotency in Xenopus laevis

  2026-09-03

  Phelps and colleagues show that hybridization remodeled early embryonic gene regulation in allotetraploid Xenopus laevis, causing divergent activation of L- and S-subgenome homeologs while preserving the total dosage of core pluripotency genes. By combining homeolog-resolved RNA sequencing, transcriptional perturbation, chromatin accessibility profiling, and CUT&RUN, the study links altered enhancer architecture to a dosage-buffered developmental network.

• Abiraterone acetate in 3D Prostate Models

  2026-09-02

  Build a translational workflow around Abiraterone acetate, from solvent-controlled dose response to patient-derived prostate spheroids. The approach separates CYP17 pathway engagement from simple viability loss, helping researchers interpret why three-dimensional cultures may respond differently from conventional cell lines.

• GDC-0994: ERK1/2 Inhibition Workflow

  2026-09-02

  GDC-0994 is a potent, selective ERK1/2 inhibitor for testing MAP kinase dependence in mutant RAS/BRAF cancer models and ERK-linked cholestasis assays. This practical guide covers compound preparation, phosphoprotein validation, zebrafish endpoints, dose optimization, and troubleshooting across both applications.

• CDK4/6–BET Synergy in Pancreatic Cancer

  2026-09-01

  Gu et al. show that combining the CDK4/6 inhibitor palbociclib with the BET inhibitor JQ1 can counter a major limitation of CDK4/6 blockade in pancreatic ductal adenocarcinoma: increased migration, invasion, and epithelial-to-mesenchymal transition. The study links this synergy to coordinated regulation of GSK3β-mediated Wnt/β-catenin signaling and TGF-β/Smad crosstalk, providing a mechanistic rationale for combination treatment.

• Losartan and AT1 Signaling: From Vessels to Tumors

  2026-09-01

  Losartan is an angiotensin II receptor antagonist used to dissect AT1 signaling in vascular and stromal biology. This article connects hypertension research with tumor-microenvironment assay design while clarifying what recent ARB evidence does—and does not—demonstrate.

• Glabridin–Gold(I) Complex Reprograms Tumor Immunity

  2026-08-31

  The reference study introduces complex 6d, which combines an N-heterocyclic carbene gold(I) center with glabridin to coordinate TrxR and MAPK pathway modulation. In liver cancer models, this design strengthens dendritic-cell activity while reducing several immunosuppressive cell populations, providing a mechanistic basis for combination strategies with cancer immunotherapy.

• Y-27632 dihydrochloride in Gut–Brain Assays

  2026-08-31

  Discover how Y-27632 dihydrochloride can function not only as a ROCK inhibitor for cell survival, but also as a mechanistic control in gut-to-vagus α-synuclein studies. This article translates a novel organoid–neuron model into practical assay-design decisions while separating established evidence from testable hypotheses.

• Quercetin, Hippo Signaling, and Cataract Protection

  2026-08-30

  The reference study combines network pharmacology with mouse and lens epithelial-cell experiments to investigate how quercetin protects against cataract-associated damage. Its results link quercetin to reduced oxidative stress, improved epithelial-cell survival, and suppression of Hippo pathway activity, while α-hederin reverses several of these effects.

• Live-Dead Cell Staining Kit: 5 Lab Scenarios

  2026-08-29

  This scenario-driven guide explains how the Live-Dead Cell Staining Kit, SKU K2081, supports defensible cell viability, cytotoxicity, and membrane-integrity measurements. It connects Calcein-AM Propidium Iodide staining principles with practical controls, imaging, flow cytometry, biomaterial testing, and vendor-selection criteria.

• Direct Mouse Genotyping Kit Plus for SCA3 Models

  2026-08-28

  The Direct Mouse Genotyping Kit Plus enables direct PCR from mouse-tissue lysates with a PCR master mix with dye reagents. It can streamline genotype confirmation for transgene detection in mice, gene knockout validation, and animal colony genetic screening, while remaining distinct from phenotyping or clinical testing.

8187 records 2/546 page Previous Next 12345 下5页 Last page